Health Care: Drugs

Illumina Inc (ILMN: NASDAQ)

$163.37 n/a | n/a%
02/17/17 - 04:00 PM ET
Company Income Statement
Dec 2016 Dec 2015 Dec 2014 Dec 2013
Sales 2.40B 2.22B 1.86B 1.42B
Cost of Sales 561.28M 505.54M 413.00M 375.13M
Gross Operating Profit 1.84B 1.71B 1.45B 1.05B
Selling, General, and Administrative Expenses 583.00M 524.66M 466.28M 394.66M
Research & Development 504.42M 401.53M 388.06M 276.74M
Operating Income before D & A (EBITDA) 749.67M 788.04M 594.01M 374.64M
Depreciation & Amortization 170.65M 164.94M 150.64M 134.16M
Interest Income 9.80M 5.02M 3.90M 4.89M
Other Income - Net -11.02M 13.49M -25.49M 71.63M
Special Income / Charges 8.00M -22.51M 66.06M -129.61M
Total Income Before Interest Expenses (EBIT) 585.82M 625.23M 490.49M 199.00M
Interest Expense 33.18M 42.12M 41.73M 39.69M
Pre-Tax Income 552.63M 583.11M 448.76M 159.31M
Income Taxes 133.09M 125.75M 95.41M 34.01M
Minority Interest -34.56M -4.17M 0.00 0.00
Net Income From Continuing Operations 428.09M 457.39M 353.35M 125.31M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 428.09M 457.39M 353.35M 125.31M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 454.11M 461.53M 353.35M 125.31M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
420.09M 473.78M 284.65M 243.30M
Preferred Dividends
Net Income Available To Common 428.09M 457.39M 353.35M 125.31M
Basic EPS from Continuing Ops. 3.09 3.19 2.61 1.00
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 3.09 3.19 2.61 1.00
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 3.09 3.19 2.61 1.00
Basic Normalized Net Income/Share 3.03 3.30 2.10 1.94
EPS fr Continuing Ops. 3.07 3.10 2.37 0.90
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 3.07 3.10 2.37 0.90
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 3.07 3.10 2.37 0.90
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
3.01 3.21 1.91 1.75
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with ILMN

Latest ILMN Headlines from TheStreet

More Financial News for ILMN

Press Releases for ILMN

See All Press Releases

Partner Headlines for ILMN

brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter